Recombinant Rat DPP3 Protein，Strep & His

Dipeptidyl peptidase III (DPP3) is a membrane-bound enzyme that plays a crucial role in the metabolism of bioactive peptides and is implicated in various physiological processes, including blood pressure regulation and neuropeptide processing. Its involvement in health and disease has attracted significant research interest, particularly in the context of cardiovascular and neurodegenerative disorders. DPP3 is known to exhibit peptidase activity, contributing to the inactivation of a range of peptides such as angiotensin II and substance P, which are key regulators of cardiovascular function and neuronal signaling, respectively. Recent studies have suggested that DPP3 may also be linked to inflammatory responses and cancer progression, highlighting its potential as a therapeutic target. The development of recombinant DPP3 protein allows for in-depth biochemical characterization and facilitates the exploration of its substrate specificity and inhibitor design, which is critical for understanding its role in pathophysiological conditions. Furthermore, generating a stable and active form of DPP3 through recombinant techniques provides a valuable tool for drug discovery and the development of novel therapeutic strategies aimed at modulating its activity for clinical benefits. As research on DPP3 continues to evolve, the recombinant protein holds promise for unraveling the complexities of its biological functions and therapeutic potential.